| NaH2PO4 |
drug |
9 |
4 |
NaH2PO4, sodium dihydrogen phosphate |
| NaHCO3 |
drug |
12 |
6 |
NaHCO3, Sodium bicarbonate, sodium bicarbonate |
| NALCN |
gene |
3 |
1 |
|
| naloxone |
drug |
14 |
10 |
10 mg/70 kg naloxone, Hospira Inc. naloxone, naloxone, naloxone reversal |
| naltrexone |
drug |
23 |
18 |
NTX, long-acting naltrexone, mOR antagonist naltrexone, medication, naltrexone, opiate antagonist, opioid antagonist naltrexone, opioid receptor antagonist, oral naltrexone |
| Nanodrop |
drug |
8 |
4 |
NanoDrop Technologies, Nanodrop, Nanodrop Technologies, Nanodrop® |
| Nanog |
gene |
10 |
3 |
Nanog |
| NaOH |
drug |
6 |
2 |
0.07 N NaOH, sodium hydroxide |
| narrow-sense heritability |
phenotype |
2 |
2 |
h2 |
| NASH |
phenotype |
3 |
2 |
non-alcoholic steatohepatitis |
| NAT2 |
gene |
2 |
2 |
N-acetyl-transferase, N-acetyltransferase 2 |
| National Cancer Institute |
cohort |
6 |
2 |
NCI |
| National Center for Health Statistics |
cohort |
4 |
— |
NCHS |
| National Death Index |
cohort |
3 |
1 |
NDI |
| National Epidemiologic Survey on Alcohol and Related Conditions |
cohort |
18 |
6 |
NESARC |
| National Institute on Alcohol Abuse and Alcoholism |
cohort |
2 |
2 |
NIAAA |
| National Institute on Drug Abuse |
cohort |
3 |
— |
NIDA |
| National Institutes of Health |
cohort |
4 |
— |
NIH |
| National Survey on Drug Use and Health |
cohort |
6 |
4 |
NSDUH |
| Native Americans |
cohort |
20 |
11 |
NA, Native, Native American, Native American ancestry, Native American samples, Native Americans, Native Ancestry, mean Native American ancestry |
